Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Boule homolog, RNA binding protein (BOLL) is a member of the DAZ gene family, which is required for germ cell development, specifically during spermatogenesis. The BOLL gene encodes an RNA-binding protein structurally more similar to Drosophila Boule than to other human DAZ family members. Loss of BOLL function leads to male infertility, primarily through a block at the meiotic G2/M transition, resulting in azoospermia (absence of sperm in semen). The protein may regulate the translation of specific mRNAs by binding their 3’-UTRs. Although BOLL has been associated with several malignancies in the literature, there is no evidence identifying it as a therapeutic target, nor are there approved drugs that interact directly with BOLL. Its primary clinical role lies in reproduction and fertility, with some research interest in cancer correlation
Not applicable; no known drugs target this molecule.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Boule homolog, RNA binding protein (BOLL).